Neuro-Oncology Reviews
Volume
24 Number 10
31 May 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 10, 31 May
*
Ghareghani
M, Zibara K, Rieter RJ, Rivest S.
Reduced
Melatonin Levels May Facilitate Glioblastoma Initiation in the
Subventricular Zone.
Expert
Rev Mol Med. 2022 May 16:1-8→.
doi: 10.1017/erm.2022.15→.
PMID: 35570582→.
Review˰ ˍ
Guerrini
F, Roca E, Spena G.
Supramarginal
Resection for Glioblastoma: It Is Time to Set Boundaries! A
Critical Review on a Hot Topic.
Brain
Sci. 2022 May 16;12(5):652→.
doi: 10.3390/brainsci12050652→.
PMID: 35625037→.
Review. ˍ
Smith
HL, Wadhwani N, Horbinski C.
Major
Features of the 2021 WHO Classification of CNS
Tumors.
Neurotherapeutics.
2022 May 16→.
doi: 10.1007/s13311-022-01249-0→.
PMID: 35578106→.
Review˰ ˍ
Manan
AA, Yahya N, Idris Z, Manan HA.
The
Utilization of Diffusion Tensor Imaging as an Image-Guided Tool in
Brain Tumor Resection Surgery: A Systematic Review.
Cancers
(Basel). 2022 May 17;14(10):2466→.
doi: 10.3390/cancers14102466→.
PMID: 35626069→.
Review. ˍ
Rasheed
S, Rehman K, Shahid M, Suhail S, Akash MSH.
Therapeutic
potentials of genistein: New insights and perspectives.
J
Food Biochem. 2022 May 17:e14228→.
doi: 10.1111/jfbc.14228→.
PMID: 35579327→.
Review˰ ˍ
Solipuram
V, Soltani R, Venkatesulu BP, Annam S, Alavian F, Ghasemi
S.
Efficacy
of Anti-VEGF Drugs Based Combination Therapies in Recurrent
Glioblastoma: Systematic Review and Meta-Analysis.
Curr
Rev Clin Exp Pharmacol. 2022 May 17→.
doi: 10.2174/2772432817666220517163609→.
PMID: 35585804→.
Review, Meta-analysis˰ ˍ
Strong
MJ, Koduri S, Allison JA, Pesavento CM, Ogunsola S, Ogunsola O,
Yee TJ, Khalsa SSS, Saadeh YS, Joseph JR, Kashlan ON, Park P,
Oppenlander ME, Szerlip NJ.
Bone
metastasis from glioblastoma: a systematic review.
J
Neurooncol. 2022 May 17→.
doi: 10.1007/s11060-022-04025-4→.
PMID: 35578056→.
Review˰ ˍ
Vogelbaum
MA, Li G, Heimberger AB, Lang FF, Fueyo J, Gomez-Manzano C, Sanai
N.
A
Window of Opportunity to Overcome Therapeutic Failure in
Neuro-Oncology.
Am
Soc Clin Oncol Educ Book. 2022 May 17;42:1-8→.
doi: 10.1200/EDBK_349175→.
PMID: 35580289→.
Review. ˍ
Heinzelmann
M, Pan E.
Post-Traumatic
Gliomas in Adults: Review of the Case Reports and Studies.
Can
J Neurol Sci. 2022 May 18:1-8→.
doi: 10.1017/cjn.2022.31→.
PMID: 35581937→.
Review˰ ˍ
Mungur
R, Zheng J, Wang B, Chen X, Zhan R, Tong Y.
Low-Intensity
Focused Ultrasound Technique in Glioblastoma Multiforme
Treatment.
Front
Oncol. 2022 May 19;12:903059→.
doi: 10.3389/fonc.2022.903059→.
PMID: 35677164→.
Review.
ˍ
Palmisciano
P, Ferini G, Watanabe G, Ogasawara C, Lesha E, Bin-Alamer O, Umana
GE, Yu K, Cohen-Gadol AA, El Ahmadieh TY, Haider AS.
Gliomas
Infiltrating the Corpus Callosum: A Systematic Review of the
Literature.
Cancers
(Basel). 2022 May 19;14(10):2507→.
doi: 10.3390/cancers14102507→.
PMID: 35626112→.
Review. ˍ
*
Damodharan
S, Lara-Velazquez M, Williamsen BC, Helgager J, Dey M.
Diffuse
Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment
Strategies and Emerging Clinical Trials.
J
Pers Med. 2022 May 20;12(5):840→.
doi: 10.3390/jpm12050840→.
PMID: 35629262→.
Review. ˍ
Gielen
GH, Baugh JN, van Vuurden DG, Veldhuijzen van Zanten SEM, Hargrave
D, Massimino M, Biassoni V, Morales la Madrid A, Karremann M,
Wiese M, Thomale U, Janssens GO, von Bueren AO, Perwein T,
Nussbaumer G, Hoving EW, Niehusmann P, Gessi M, Kwiecien R, Bailey
S, Pietsch T, Andreiuolo F, Kramm CM.
Pediatric
high-grade gliomas and the WHO CNS Tumor
Classification-Perspectives of pediatric neuro-oncologists and
neuropathologists in light of recent updates.
Neurooncol
Adv. 2022 May 20;4(1):vdac077→.
doi: 10.1093/noajnl/vdac077→.
PMID: 35733513→.
Survey. ˍ
Guo
X, Jiao H, Zhang T, Zhang Y.
Pre-Treatment
and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts
Prognostic Value of Glioblastoma: A Meta-Analysis.
Brain
Sci. 2022 May 21;12(5):675→.
doi: 10.3390/brainsci12050675→.
PMID: 35625061→.
Meta-analysis. ˍ
Bhandari
A, Marwah R, Smith J, Nguyen D, Bhatti A, Lim CP, Lasocki
A.
Machine
learning imaging applications in the differentiation of true
tumour progression from treatment-related effects in brain
tumours: A systematic review and meta-analysis.
J
Med Imaging Radiat Oncol. 2022 May 22→.
doi: 10.1111/1754-9485.13436→.
PMID: 35599360→.
Review. ˍ
Brown
CE, Bucktrout S, Butterfield LH, Futer O, Galanis E, Hormigo A,
Lim M, Okada H, Prins R, Marr SS, Tanner K.
The
future of cancer immunotherapy for brain tumors: a collaborative
workshop.
J
Transl Med. 2022 May 23;20(1):236→.
doi: 10.1186/s12967-022-03438-z→.
PMID: 35606815→.
Meeting report. ˍ
Folloso MC, Torres M, Ciocon SL,
Ong JN, Flores JA, Catindig JA.
Therapeutic
role of memantine for the prevention of cognitive decline in
cancer patients with brain metastasis receiving whole-brain
radiotherapy: a narrative review.
Dement
Neuropsychol. 2022 May 23, 2022;16(3):270-275→.
doi: 10.1590/1980-5764-DN-2021-0102→.
PMID: 36619840→.
Review. ˍ
McAleavey
PG, Walls GM, Chalmers AJ.
Radiotherapy-drug
combinations in the treatment of glioblastoma: a brief review.
CNS
Oncol. 2022 May 23, 2022 Jun 1;11(2):CNS86→.
doi: 10.2217/cns-2021-0015→.
PMID: 35603818→.
Review. ˍ
von
Knebel Doeberitz N, Paech D, Sturm D, Pusch S, Turcan S,
Saunthararajah Y.
Changing
paradigms in oncology: toward non-cytotoxic treatments for
advanced gliomas.
Int
J Cancer. 2022 May 23→.
doi: 10.1002/ijc.34131→.
PMID: 35603902→.
Review. ˍ
Bernstock
JD, Gary SE, Klinger N, Valdes PA, Ibn Essayed W, Olsen HE,
Chagoya G, Elsayed G, Yamashita D, Schuss P, Gessler FA, Paolo
Peruzzi P, Bag AK, Friedman GK.
Standard
clinical approaches and emerging modalities for glioblastoma
imaging.
Neurooncol
Adv. 2022 May 26;4(1):vdac080→.
doi: 10.1093/noajnl/vdac080→.
PMID: 35821676→.
Review. ˍ
Smiley
SB, Zarrinmayeh H, Das SK, Pollok KE, Vannier MW, Veronesi
MC.
Novel
therapeutics and drug-delivery approaches in the modulation of
glioblastoma stem cell resistance.
Ther
Deliv. 2022 May 26, 2022 Apr;13(4):249-273→.
doi: 10.4155/tde-2021-0086→.
PMID: 35615860→.
Review. ˍ
Jang
JK, Pyo J, Suh CH, Park HS, Chae YK, Kim KW.
Safety
and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for
Glioblastoma: A Systemic Review and Meta-Analysis.
Front
Oncol. 2022 May 26;12:851877→.
doi: 10.3389/fonc.2022.851877→.
PMID: 35692797→.
Review, Meta-analysis. ˍ
Rizzo
A, Savjani R.
The
Current Landscape of Clinical Predictions from Brain Tumor
Imaging.
Radiol
Imaging Cancer. 2022 May 27;4(3):e229011→.
doi: 10.1148/rycan.229011→.
PMID: 35621523→.
Review. ˍ
Greuter
L, Frank N, Guzman R, Soleman J.
The
Clinical Applications of Liquid Biopsies in Pediatric Brain
Tumors: A Systematic Literature Review.
Cancers
(Basel). 2022 May 28;14(11):2683→.
doi: 10.3390/cancers14112683→.
PMID: 35681663→.
Review.
ˍ
Halasz
LM, Attia A, Bradfield L, Brat DJ, Kirkpatrick JP, Laack NN,
Lalani N, Lebow ES, Liu AK, Niemeier HM, Palmer JD, Peters KB,
Sheehan J, Thomas RP, Vora SA, Wahl DR, Weiss SE, Yeboa DN, Zhong
J, Shih HA.
Radiation
Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An
ASTRO Clinical Practice Guideline.
Pract
Radiat Oncol. 2022 May 31:S1879-8500(22)00144-8→.
doi: 10.1016/j.prro.2022.05.004→.
PMID: 35902341→.
Guidelines. ˍ
Melhem
JM, Detsky J, Lim-Fat MJ, Perry JR.
Updates
in IDH-Wildtype Glioblastoma.
Neurotherapeutics.
2022 May 31:1–19→.
doi: 10.1007/s13311-022-01251-6→.
PMID: 35641844→.
Review. ˍ
*
Tozzi
AE, Fabozzi F, Eckley M, Croci I, Dell'Anna VA, Colantonio E,
Mastronuzzi A.
Gaps
and Opportunities of Artificial Intelligence Applications for
Pediatric Oncology in European Research: A Systematic Review of
Reviews and a Bibliometric Analysis.
Front
Oncol. 2022 May 31;12:905770→.
doi: 10.3389/fonc.2022.905770→.
PMID: 35712463→.
Review, Bibliometric analysis. ˍ